218 related articles for article (PubMed ID: 26248153)
1. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation.
Reiter MJ; Costello JE; Schwope RB; Lisanti CJ; Osswald MB
J Comput Assist Tomogr; 2015; 39(6):825-34. PubMed ID: 26248153
[TBL] [Abstract][Full Text] [Related]
2. Molecular methods for the diagnosis of cancer.
Cairns P; Sidransky D
Biochim Biophys Acta; 1999 Mar; 1423(2):C11-8. PubMed ID: 10214347
[No Abstract] [Full Text] [Related]
3. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
Bekci TT; Senol T; Maden E
J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages.
Wu JT; Erickson AJ; Tsao KC; Wu TL; Sun CF
Ann Clin Lab Sci; 2000 Apr; 30(2):175-8. PubMed ID: 10807161
[TBL] [Abstract][Full Text] [Related]
5. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers in hemodialysis patients.
Arican A; Ozdemir N; Sezer S; Erten Y; Güz G; Turan M; Inanoglu I; Haberal M
Transplant Proc; 1999 Dec; 31(8):3367-8. PubMed ID: 10616509
[No Abstract] [Full Text] [Related]
7. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
[TBL] [Abstract][Full Text] [Related]
8. [Value of serum tumor markers for the early diagnosis of neoplasm and in health exams for asymptomatic persons].
Bernabé Caro R; Moreno Nogueira JA
Rev Clin Esp; 2002 Apr; 202(4):212-4. PubMed ID: 12003731
[No Abstract] [Full Text] [Related]
9. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring.
Bidart JM; Thuillier F; Augereau C; Chalas J; Daver A; Jacob N; Labrousse F; Voitot H
Clin Chem; 1999 Oct; 45(10):1695-707. PubMed ID: 10508114
[TBL] [Abstract][Full Text] [Related]
10. [Tumor markers in gynecology].
Alekseeva ML; Fanchenko ND; Novikov EA; Margiani FR
Akush Ginekol (Mosk); 1995; (5):35-7. PubMed ID: 8579206
[No Abstract] [Full Text] [Related]
11. Tumour markers.
Pandha HS; Waxman J
QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of tumor markers in childhood malignancies.
Labdenne P; Heikinheimo M
Ann Med; 2002; 34(5):316-23. PubMed ID: 12452476
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.
Kirwan A; Utratna M; O'Dwyer ME; Joshi L; Kilcoyne M
Biomed Res Int; 2015; 2015():490531. PubMed ID: 26509158
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study.
Turgutalp K; Ozhan O; Helvacı I; Ata A; Arican A; Boztepe B; Kıykım A
Clin Chem Lab Med; 2013 Apr; 51(4):889-95. PubMed ID: 23314541
[TBL] [Abstract][Full Text] [Related]
15. Effect of obesity-related plasma hemodilution on serum tumor marker concentration in women.
Park M; Chang IH; Kang H; Han SS
J Obstet Gynaecol Res; 2015 May; 41(5):784-9. PubMed ID: 25421332
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in the treatment of cancer: opportunities and pitfalls.
Melichar B
Clin Chem Lab Med; 2013 Jul; 51(7):1329-33. PubMed ID: 23729626
[No Abstract] [Full Text] [Related]
17. Tumour markers with clinically controlled cut-offs for suspected cancer.
Bosch X; Molina R; Marrades R; Augé JM; Pellicé M; López-Soto A
Eur J Clin Invest; 2021 Jul; 51(7):e13523. PubMed ID: 33594702
[TBL] [Abstract][Full Text] [Related]
18. Interlaboratory surveys of the determination of tumour markers scatter and repeatability of the results.
Kruse R; Geilenkeuser WJ; Röhle G
Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):139-46. PubMed ID: 7683915
[TBL] [Abstract][Full Text] [Related]
19. [Conventional serum tumor markers in liver cancer. Retrospective analysis of 118 patients].
Arias-Flórez JS; Martínez-Delgado AM; Alarcón-Tarazona ML; Insuasty-Enriquez JS; Díaz-Martínez LA
Rev Med Chil; 2018 Dec; 146(12):1422-1428. PubMed ID: 30848745
[TBL] [Abstract][Full Text] [Related]
20. Tumor markers in clinical practice: a review focusing on common solid cancers.
Duffy MJ
Med Princ Pract; 2013; 22(1):4-11. PubMed ID: 22584792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]